MLYS – mineralys therapeutics, inc. (US:NASDAQ)

News

Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer
Is It Time To Reassess Mineralys Therapeutics (MLYS) After The Recent Share Price Pullback? [Yahoo! Finance]
R1 starts up with $78M, aiming for a better kidney drug [Yahoo! Finance]
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Mineralys Therapeutics (MLYS) was upgraded by Wall Street Zen from "s
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com